Enveric Biosciences, Inc.
ENVB
$1.45
$0.12089.09%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -18.64% | -32.44% | -2.05% | -27.07% | -50.54% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -45.49% | -30.75% | 1.01% | -62.29% | -55.30% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -99.68% | -99.94% | -71.26% | 112.15% | 351.82% |
Total Current Assets | -40.08% | -41.25% | -23.65% | -25.55% | -37.98% |
|
|||||
Total Current Assets | -40.08% | -41.25% | -23.65% | -25.55% | -37.98% |
Net Property, Plant & Equipment | -40.48% | -40.89% | -39.73% | -31.81% | -33.02% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -79.99% | -66.65% | -57.13% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -41.36% | -42.35% | -28.31% | -27.63% | -38.25% |
|
|||||
Total Accounts Payable | 126.35% | -63.88% | -57.20% | -47.52% | -62.75% |
Total Accrued Expenses | 26.30% | 32.98% | 25.25% | -72.66% | -77.38% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -87.25% | -94.28% | -99.55% | -99.69% |
Total Other Current Liabilities | -- | -87.25% | -94.28% | -99.55% | -99.69% |
Total Current Liabilities | 111.33% | -49.98% | -36.43% | -79.94% | -86.90% |
|
|||||
Total Current Liabilities | 111.33% | -49.98% | -36.43% | -79.94% | -86.90% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 111.33% | -49.98% | -36.43% | -79.94% | -86.90% |
|
|||||
Common Stock & APIC | 6.30% | 6.40% | 7.36% | 11.84% | 11.65% |
Retained Earnings | -9.86% | -9.40% | -9.92% | -10.59% | -11.74% |
Treasury Stock & Other | -1.24% | -8.37% | 75.10% | 0.11% | -3.74% |
Total Common Equity | -59.59% | -39.56% | -18.58% | 62.23% | 10.91% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -59.59% | -39.56% | -18.58% | 62.23% | 10.91% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -59.59% | -39.56% | -18.58% | 62.23% | 10.91% |
|